Histopathology of Basal Cell Carcinoma After Treatment With Vismogedib
Conclusion: The histologic findings of BCCs treated with vismodegib correlate with clinical response.
J Drugs Dermatol. 2019;18(2):136-138.
PMID: 30794363 [PubMed - as supplied by publisher]
Source: Journal of Drugs in Dermatology - Category: Dermatology Tags: J Drugs Dermatol Source Type: research
More News: Basal Cell Carcinoma | Cancer & Oncology | Carcinoma | Dermatology | Skin | Skin Cancer | Study